Showing Results for: “type 1 diabetes”

The American Diabetes Association® (ADA) announced on July 8 that Chief Scientific and Medical Officer (CSMO) Dr. Robert Gabbay has chosen to step down from his role to reduce his professional commitments and transition into semi-retirement. Dr. Gabbay's last day will be September 6. “We owe a debt of gratitude to Dr. Bob for his unwavering dedication and the profound impact he has made during his tenure,” said Charles “Chuck” Henderson, chief executive officer of the ADA. “As we move forward, guided by his legacy and the enduring deep expertise of the ADA’s Science and Health Care team, I am